Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Other Non-Current Assets (2020 - 2025)

Mirum Pharmaceuticals has reported Other Non-Current Assets over the past 6 years, most recently at $12.0 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $12.0 million for Q4 2025, up 123.3% from a year ago — trailing twelve months through Dec 2025 was $12.0 million (up 123.3% YoY), and the annual figure for FY2025 was $12.0 million, up 123.3%.
  • Other Non-Current Assets for Q4 2025 was $12.0 million at Mirum Pharmaceuticals, up from $9.9 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for MIRM hit a ceiling of $12.0 million in Q4 2025 and a floor of $250000.0 in Q2 2024.
  • Median Other Non-Current Assets over the past 5 years was $1.7 million (2021), compared with a mean of $3.0 million.
  • Biggest five-year swings in Other Non-Current Assets: soared 791.25% in 2021 and later plummeted 89.03% in 2025.
  • Mirum Pharmaceuticals' Other Non-Current Assets stood at $1.8 million in 2021, then dropped by 22.62% to $1.4 million in 2022, then soared by 201.37% to $4.2 million in 2023, then grew by 29.22% to $5.4 million in 2024, then skyrocketed by 123.3% to $12.0 million in 2025.
  • The last three reported values for Other Non-Current Assets were $12.0 million (Q4 2025), $9.9 million (Q3 2025), and $480000.0 (Q2 2025) per Business Quant data.